Buy signal, 10th week
Eli Lilly gains 1.4%, bounces off the EMA20 just shy of its highs
Buy signal, 10th week
Our view last week
Eli Lilly shares slip 0.8% in a cautious week — volumes contracting, mixed rejection bars — but underneath, the picture holds: a double bottom in the 1090 area has already delivered a 10% rebound, and the weekly ADX is climbing, a sign the trend is gaining conviction. This week's technical analysis finds the buy signal in its 9th week, with the trade up more than 17%.
This week's summary
Eli Lilly shares close the week up 1.4%, rebounding 4% off the daily EMA20 after a touch in the 1150 area. The buy signal is in its 10th week and the trade is running at +19% since entry, but the stock is hugging its all-time highs, already tested multiple times: little room to run without a pullback. This week's technical analysis shows the structure still bullish, with the weekly ADX climbing.
IQS Phase
63
ordinary
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#32 / 124
US stocks in progress
Trade P&L %
+19.02%
from signal to today
Rank position
ranks 32nd among the 124 Longs already running for US stocks in our ranking, with a signal strength of 66 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
LLY belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content